piperidinoethyl chloride | 100859-97-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: piperidinoethyl chloride
• 英文别名: N-chloroethylpiperidine；chloroethylpiperidine；N-β-chloroethylpiperidine；piperidino-ethyl-chloride；N-β-Chlorethylpiperidin；1-(1-Chloroethyl)piperidine
• CAS: 100859-97-0
• 化学式: C₇H₁₄ClN
• 分子量: 147.648
• InChiKey: OTYSWRSTJVYPLS-UHFFFAOYSA-N

物化性质

• 沸点：
  168.0±23.0 °C(Predicted)
• 密度：
  1.021±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  sodium salt of 4-(3-hydroxyphenoxy)-2-amino-nitrobenzene 、 piperidinoethyl chloride 以 溶剂黄146 、 丙酮 为溶剂， 生成 4-[3-(2-piperidyl-ethoxy)-phenoxy]-2-amino-nitrobenzene
  参考文献：
  名称：

  Anthelmintically active basically substituted

  摘要：

  本文披露了具有驱虫活性的基本上取代的2-羰基氨基苯并唑基-5(6)-苯醚和酮，以及制备它们的过程。这些化合物是化疗药物，对蛔虫、其他蠕虫以及肝吸虫具有特殊活性。

  公开号：

  US04010272A1

文献信息

• Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
  申请人：Zhou Cangyou

  公开号：US20050250814A1

  公开（公告）日：2005-11-10

  The present invention is directed to compounds of the formula I: (wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , W, X, Z, m and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.

  本发明涉及具有以下式I的化合物：（其中R1、R2、R3、R4、R5、R6、W、X、Z、m和n在此处定义），这些化合物可用作趋化因子受体活性的调节剂。特别是，这些化合物可用作趋化因子受体CCR-2的调节剂。
• COMPLEX AND STRUCTURALLY DIVERSE COMPOUNDS
  申请人：The Board of Trustees of the University of Illinois

  公开号：US20150274638A1

  公开（公告）日：2015-10-01

  The invention provides a novel, general, and facile strategy for the creation of small molecules with high structural and stereochemical complexity. Aspects of the methods include ring system distortion reactions that are systematically applied to rapidly convert readily available natural products to structurally complex compounds with diverse molecular architectures. Through evaluation of chemical properties including fraction of sp 3 carbons, ClogP, and the number of stereogenic centers, these compounds are shown to be significantly more complex and diverse than those in standard screening collections. This approach is demonstrated with natural products (gibberellic acid, adrenosterone, and quinine) from three different structural classes, and methods are described for the application of this strategy to any suitable natural product.

  这项发明提供了一种新颖、通用且简便的策略，用于创造具有高结构和立体化学复杂性的小分子。该方法的方面包括系统地应用于快速将易得的天然产物转化为具有多样分子结构的结构复杂化合物的环系统失真反应。通过评估化学性质，包括sp3碳的分数、ClogP和立体中心的数量，这些化合物被证明比标准筛选集合中的化合物显着更复杂和多样化。这种方法是通过来自三个不同结构类别的天然产物（赤霉酸、肾上腺酮和奎宁）来展示的，并描述了将该策略应用于任何合适的天然产物的方法。
• Halo-containing 3-methylflavone-8-carboxylic acid derivatives
  申请人：Yamamoto Chemical Industrial Co., Ltd.

  公开号：US04634768A1

  公开（公告）日：1987-01-06

  This invention relates to derivatives of 3-methylflavone-8-carboxylic acid represented by the formula (1) ##STR1## wherein R represents a hydrogen atom, a lower alkyl group or a group ##STR2## (wherein R.sup.1 and R.sup.2 represent a lower alkyl group or R.sup.1 and R.sup.2, when taken together with the nitrogen atom to which they are attached, may form a heterocyclic ring with or without an intervening hetero atom, and n is an integer of 1 to 4), and X represents a halogen atom, which are useful as intermediates. This invention also relates to processes for preparing the same.

  这项发明涉及由式（1）表示的3-甲基黄酮-8-羧酸衍生物 ##STR1## 其中R代表氢原子、较低的烷基基团或基团 ##STR2## （其中R.sup.1和R.sup.2代表较低的烷基基团或R.sup.1和R.sup.2，当与它们连接的氮原子一起时，可以形成具有或不具有介入杂原子的杂环环，n为1至4的整数），X代表卤原子，这些衍生物可用作中间体。这项发明还涉及制备这些衍生物的方法。
• Composition, synthesis and therapeutic applications of polyamines
  申请人：Murphy A Michael

  公开号：US20050085555A1

  公开（公告）日：2005-04-21

  This invention relates to a process of synthesis and composition of open chain (ring), closed ring, linear branched and or substituted polyamines, polyamine derived tyrosine phosphatase inhibitors and PPAR partial agonists/partial antagonists via a series of substitution reactions and optimizing the bioavailability and biological activities of the compounds. Polyamines prevent the toxicty of neutoxins and diabetogenic toxins including paraquat, methyphenyl pyridine radical, rotenone, diazoxide, streptozotocin and alloxan. These polyamines can be to treat neurological, cardiovascular, endocrine acquired and inherited mitochondrial DNA damage diseases and other disorders in mammalian subjects, and more specifically to the therapy of Parkinson's disease, Alzheimer's disease, Lou Gehrig's disease, Binswanger's disease, Olivopontine Cerebellar Degeneration, Lewy Body disease, Diabetes, Stroke, Atherosclerosis, Myocardial Ischemia, Cardiomyopathy, Nephropathy, Ischemia, Glaucoma, Presbycussis, Cancer, Osteoporosis, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis and as Antidotes to Toxin Exposure.

  这项发明涉及一种合成和构成开链（环）、闭环、线性分支和/或取代聚胺、聚胺衍生的酪氨酸磷酸酶抑制剂和PPAR部分激动剂/部分拮抗剂的过程，通过一系列的取代反应来优化化合物的生物利用度和生物活性。聚胺可以预防神经毒素和导致糖尿病的毒素的毒性，包括百草枯、甲基苯基吡啶自由基、洛特侬、重组蛋白酶和阿洛克瑞。这些聚胺可以用于治疗哺乳动物主体中的神经系统、心血管系统、内分泌系统获得性和遗传性线粒体DNA损伤疾病以及其他疾病，更具体地用于治疗帕金森病、阿尔茨海默病、路易氏氏病、宾斯旺格氏病、橄榄桥小脑变性、Lewy小体病、糖尿病、中风、动脉粥样硬化、心肌缺血、心肌病、肾病、缺血、青光眼、老年性耳聋、癌症、骨质疏松症、类风湿性关节炎、炎症性肠病、多发性硬化症以及作为毒素暴露的解毒剂。
• SHIKIMATE PATHWAY INHIBITORS AND THE USE THEREOF
  申请人：NATIONAL TSING HUA UNIVERSITY

  公开号：US20150141357A1

  公开（公告）日：2015-05-21

  The present invention relates to methods of inhibiting shikimate pathway, comprising administering to a subject a pharmaceutically acceptable composition comprising a compound having a formula: or pharmaceutically acceptable salts thereof. The present invention also provides a synergistic antibacterial composition containing compound

  本发明涉及抑制植酸途径的方法，包括向受试者施用含有以下结构式的化合物或其药学上可接受的盐的药学上可接受的组合物。本发明还提供了一种含有该化合物的协同抗菌组合物。